Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China · Delayed Price · Currency is CNY 28.56
-2.89 (-9.19%)
Sep 15, 2026, 11:24 AM CST
SHA:603983 Revenue
Guangdong Marubi Biotechnology had revenue of 781.79M CNY in the quarter ending June 30, 2026, a decrease of -14.84%. This brings the company's revenue in the last twelve months to 3.36B, down -0.72% year-over-year. In the year 2025, Guangdong Marubi Biotechnology had annual revenue of 3.46B with 16.48% growth.
Revenue (ttm)
3.36B
Revenue Growth
-0.72%
P/S Ratio
3.76
Revenue / Employee
2.43M
Employees
1,380
Market Cap
12.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.46B | 489.55M | 16.48% |
| Dec 31, 2024 | 2.97B | 744.18M | 33.44% |
| Dec 31, 2023 | 2.23B | 493.88M | 28.52% |
| Dec 31, 2022 | 1.73B | -55.31M | -3.10% |
| Dec 31, 2021 | 1.79B | 42.04M | 2.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.